# IBRANCE
> **NDA212436** · New Drug Application · Sponsor: PFIZER · Approved 2019-11-01
## Drug
- **FDA Application Number:** NDA212436
- **Application type:** New Drug Application
- **Brand name:** IBRANCE
- **Generic name:** PALBOCICLIB
- **Active ingredients:** PALBOCICLIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PFIZER
- **Manufacturer:** U.S. Pharmaceuticals
- **First approval:** 2019-11-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212436)
---
*MORVS · CC0 1.0*